Ver Bilano

Ver Bilano

Novartis Pharmaceuticals UK Ltd
Verified email at novartis.com
Cited by 44311
Real-World Evidence HEOR
Steve E. Kalloger

Steve E. Kalloger

University of British Columbia
Verified email at mail.ubc.ca
Cited by 28488
HEOR shared decision making health policy statistical modeling HRQoL
Ambrish Singh

Ambrish Singh

Doctor of Philosophy (Medical Studies), Hobart, Australia
Verified email at utas.edu.au
Cited by 25529
Systematic Review HEOR Real World Evidence Meta-Analysis Pharmacoepidemiology
David Waterhouse

David Waterhouse

OHC, Cincinnati OH
Verified email at usoncology.com
Cited by 22343
Lung cancer HEOR GU tumors
Nora Janjan

Nora Janjan

CMO, STATinMED Research
Verified email at statinmed.com
Cited by 20831
HEOR
Joseph E. Bauer, PhD.

Joseph E. Bauer, PhD.

Levine Cancer Institute, Atrium Health
Verified email at atriumhealth.org
Cited by 18446
Oncology Research Cancer Control HEOR Evaluation Methods(Design/ Testing/ Biostatistics)
Yi Peng

Yi Peng

AbbVie
Verified email at abbvie.com
Cited by 6290
Real-World Evidence ITC-MAIC-NMA HEOR Epidemiology Biostatistics
Ahmed M. Soliman, MS, PhD

Ahmed M. Soliman, MS, PhD

Director, Health Economics and Outcomes Research, AbbVie Inc.
Verified email at abbvie.com
Cited by 4809
Pharmacoeconomics Health Outcomes Research Patient Reported Outcomes HEOR
Turgay Ayer

Turgay Ayer

Professor of Industrial and Systems Engineering, Georgia Tech
Verified email at isye.gatech.edu
Cited by 4620
Healthcare Analytics Health Technology Assessment HEOR Real-World Evidence Machine Learning
Finn Boerlum Børlum Kristensen

Finn Boerlum Børlum Kristensen

Professor of Health Economics and HTA, University of Southern Denmark
Verified email at dadlnet.dk
Cited by 4511
HTA HEOR Market Access
1 - 10